Search | Page 14 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Clinical Trials Report for December 2015

    ... Chemotherapy and Radiation Therapy Before Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies ... has a Fludarabine-based preparative regimen followed by an allogeneic hematopoietic stem cell transplant using related or unrelated ...

    Page last updated 11/30/2015 - 10:31am.

  2. Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation and Donor Bone Marrow Transplant in Treating Patients With Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or High-Risk Myelodysplastic Sy

    ... the patient's immune system from rejecting the donor's stem cells . Also, radiolabeled monoclonal antibodies, such as iodine I 131 ... Intervention:  Procedure: Allogeneic Bone Marrow Transplantation Given via central line Other ...

    Clinical Trial last updated 04/28/2016 - 1:01pm.

  3. Nonmyeloablative Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Sickle Cell Disease and Beta-thalassemia in People With Higher Risk of Transplant Failure

    ... Our ongoing nonmyeloablative allogeneic peripheral blood stem cell (PBSC) transplant protocol (03-H-0170) for patients with ...

    Clinical Trial last updated 04/28/2016 - 9:09am.

  4. Refining a Biobehavioral Intervention to Enhance Recovery Following Hematopoietic Stem Cell Transplantation

    ... intervention to improve the recovery following hematopoietic stem cell transplantation (HSCT). Cancer patients who were treated with HSCT ... types) receiving standard conditioning regimens Allogeneic transplant recipients undergoing fully ablative transplants ...

    Clinical Trial last updated 04/29/2016 - 10:30am.

  5. Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation Followed by Donor Bone Marrow Transplant and Cyclophosphamide, Mycophenolate Mofetil, Tacrolimus, and Sirolimus in Treating Patients With Primary Immunodeficiency Disorders or Noncancerou

    ... irradiation on day -1. TRANSPLANTATION: Patients undergo allogeneic bone marrow transplant on day 0. POST-TRANSPLANT ... Procedure: Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation Undergo allogeneic bone marrow transplantation ...

    Clinical Trial last updated 04/26/2016 - 2:09pm.

  6. Midostaurin and Azacitidine in Treating Elderly Patients With Acute Myelogenous Leukemia

    ... treatment; patients who have received prior autologous or allogeneic stem cell transplantation are not eligible; patients may have received 1 or 2 ...

    Clinical Trial last updated 06/03/2016 - 2:24pm.

  7. Busulfan and Cyclophosphamide Followed By ALLO BMT

    ... who are at least 6 months after initial hematopoietic stem cell transplant (HSCT) <45 years of age and have received ... unless no engraftment. Other Name: MMF Biological: Allogeneic hematopoietic stem cell transplant Day 0 (or Day+1/+2 to ...

    Clinical Trial last updated 04/29/2016 - 1:23pm.

  8. Clinical Trials Report for April 2014

    ... treated with drugs that suppress the immune system or with stem cell transplant. People with SAA who receive these treatments are more ... determine the incidence of grade II-IV acute GVHD following Allogeneic (allo) Hematopoeitic Cell Transplant (HCT) using post-transplant ...

    Page last updated 04/18/2014 - 3:36pm.

  9. Unrelated Donor Stem Cell Transplantation

    ... states who lack a suitable sibling donor to undergo allogeneic hematopoietic progenitor cell transplantation using cells from unrelated individuals or cord blood ...

    Clinical Trial last updated 04/28/2016 - 2:16pm.

  10. Unrelated Donor Stem Cell Transplantation

    ... states who lack a suitable sibling donor to undergo allogeneic hematopoietic progenitor cell transplantation using cells from unrelated individuals or cord blood ...

    Clinical Trial last updated 04/27/2016 - 3:18pm.